The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| SENS | +1.27% | -5.23% | -1.07% | -89% |
| S&P | +19.61% | +98.99% | +14.75% | +236% |
Senseonics Holdings, Inc. engages in the design, development, and commercialization of an implantable continuous glucose monitoring system for people with diabetes. Its primary product is the brand Eversense, a glucose monitoring device which includes sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.
Investors appear to be betting that a key regulatory approval is close at hand.
The maker of continuous glucose monitoring systems for diabetes treatment is a meme stock with some fundamental support.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $6.65M | 36.7% |
| Gross Profit | $3.12M | 947.3% |
| Gross Margin | 46.94% | 40.8% |
| Market Cap | $388.06M | 83.2% |
| Market Cap / Employee | $3.32M | 0.0% |
| Employees | 117 | -11.4% |
| Net Income | -$14.50M | 28.5% |
| EBITDA | -$13.95M | 27.1% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $31.83M | -9.5% |
| Accounts Receivable | $5.16M | 18.5% |
| Inventory | 4.7 | -34.7% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $40.78M | 1.4% |
| Short Term Debt | $0.46M | -97.6% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -52.10% | 8.6% |
| Return On Invested Capital | 85.43% | 353.8% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$9.39M | 29.0% |
| Operating Free Cash Flow | -$9.27M | 16.8% |
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | -11.11 | -18.82 | 12.20 | 4.10 | -63.32% |
| Price to Sales | 9.78 | 13.87 | 19.92 | 15.22 | 48.68% |
| Price to Tangible Book Value | 6477.04 | -332.43 | -471.89 | 177.10 | -20.72% |
| Enterprise Value to EBITDA | -10.60 | -24.84 | -34.20 | -21.64 | 60.66% |
| Return on Equity | -145.8% | -166.3% | -161.2% | -102.6% | -18.11% |
| Total Debt | $60.14M | $61.06M | $41.08M | $41.24M | -30.40% |
SENS earnings call for the period ending June 30, 2019.
SENS earnings call for the period ending March 31, 2019.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
